Tumorigenic GBM stemness signatures, including CD133, OLIG2, CD44, SOX2, Oct4, and Nanog, have been shown to induce TMZ chemoresistance in GBM [21, 22, 23, 24, 25]. This evidence concerns the gene OLIG2 and glioblastoma.